Rapid Micro Biosystems to Exhibit at the 2022 PDA Pharmaceutical Microbiology Conference
October 04 2022 - 8:30AM
Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an
innovative life sciences technology company providing mission
critical automation solutions to facilitate the efficient
manufacturing and fast, safe release of healthcare products, today
announced its participation as a sponsor and exhibitor at the 2022
Parenteral Drug Association (“PDA”) Pharmaceutical Microbiology
Conference on October 10-12, in Washington, D.C.
This year’s conference will be attended by global industry
professionals, academia and regulatory authorities and will
continue the ongoing tradition of addressing the opportunities and
challenges that will shape the future of pharmaceutical
microbiology.
“We are excited to participate in the 2022 PDA Pharmaceutical
Microbiology Conference and to showcase the capabilities of the
Growth Direct® System,” said Robert Spignesi, President and CEO of
Rapid Micro Biosystems. “The global pharmaceutical manufacturing
industry must continue to evolve to keep up with the increasing
speed and complexity of today’s drug manufacturing processes. The
Growth Direct System provides an automated platform for
microbiological quality control with greater capacity, faster
results and improved data integrity to modernize customers’
laboratory practices. The Growth Direct System is integrated into
current laboratory information management systems and is designed
to meet both today’s microbiological quality control standards and
tomorrow’s challenges.”
The Company’s exhibit booth will include an operational Growth
Direct® System to demonstrate its rapid detection technology and
the benefits of automation and digitization in the quality control
lab.
Other highlights of the conference will include:
- “Faster, Better, Smarter Monitoring
with Growth Direct,” a Tech Talk presented by Danielle DeCesaro of
Rapid Micro Biosystems, on Tuesday, October 11, beginning at
12:55pm ET
- The Company will participate in two
poster presentations:
- “Design Requirements for 21 CFR 11
Compliance and Manufacture 4.0 Readiness in a QC Microbiology
Instrument”, a poster presentation by Todd Ballantyne of Rapid
Micro Biosystems
- “Automated Optical Differentiation
of Mold from Non-Mold During Enumeration of Environmental
Monitoring (“EM”) Test Plates,” a poster presentation by Danielle
DeCesaro
- The poster presentations will occur
on Monday, October 10 at 12:15pm, 3:15pm and 5:30pm and on Tuesday,
October 11 at 10:00am, 12:15pm and 3:15pm
Investors and other interested parties are invited to register
to attend the conference at:
https://www.pda.org/global-event-calendar/event-detail/2022-pda-pharmaceutical-microbiology-conference
About Rapid Micro Biosystems
Rapid Micro Biosystems is an innovative life sciences technology
company providing mission critical automation solutions to
facilitate the efficient manufacturing and fast, safe release of
healthcare products such as biologics, vaccines, cell and gene
therapies, and sterile injectables. The Company’s flagship Growth
Direct system automates and modernizes the antiquated, manual
microbial quality control (“MQC”) testing workflows used in the
largest and most complex pharmaceutical manufacturing operations
across the globe. The Growth Direct system brings the quality
control lab to the manufacturing floor, unlocking the power of
in-line/at-the-line MQC automation to deliver faster results,
greater accuracy, increased operational efficiency, better
compliance with data integrity regulations, and quicker decision
making, that customers rely on to ensure safe and consistent supply
of important healthcare products. The Company is headquartered and
has U.S. manufacturing in Lowell, Massachusetts, with global
locations in Lexington, Massachusetts, Switzerland, Germany, and
the Netherlands. For more information, please visit
www.rapidmicrobio.com or follow the company on Twitter at
@rapidmicrobio or on LinkedIn.
Investor Contact:
Michael Beaulieu, CFA
Vice President, Investor Relations and Corporate Communications
investors@rapidmicrobio.com
Media Contact:
media@rapidmicrobio.com
Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart
From Jun 2024 to Jul 2024
Rapid Micro Biosystems (NASDAQ:RPID)
Historical Stock Chart
From Jul 2023 to Jul 2024